A detailed history of Chartwell Investment Partners, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 9,226 shares of ANIP stock, worth $550,423. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,226
Previous 10,726 13.98%
Holding current value
$550,423
Previous $742,000 20.89%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$58.53 - $68.82 $87,795 - $103,229
-1,500 Reduced 13.98%
9,226 $587,000
Q1 2024

May 14, 2024

BUY
$54.2 - $69.69 $13,766 - $17,701
254 Added 2.43%
10,726 $742,000
Q4 2023

Feb 15, 2024

BUY
$48.72 - $65.43 $226,109 - $303,660
4,641 Added 79.59%
10,472 $578,000
Q3 2023

Nov 07, 2023

BUY
$50.28 - $64.61 $293,182 - $376,740
5,831 New
5,831 $339,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.04B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.